Physician

Charis Durham, M.D.

According to 2025 Medicare claims, Charis Durham, M.D. (NPI: 1538547401) practices internal medicine in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is BRAZOS VALLEY HEMATOLOGY ONCOLOGY ASSOCIATES, PA (NPI: 1376594432; TIN: 742803009) and primary practice location at 77802-2585. Durham is affiliated with the CommonSpirit ACO I (ACO ID: A2164), participating under the MSSP model.

Durham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 555 traditional Medicare patients, billed 191,798 HCPCS/CPT codes, and received $3,305,846 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,241 prescription claims across 192 beneficiaries totaling $3,310,242 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 11 claims. Open Payments data shows 47 records totaling $1,519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,610 to $3,305,846. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,827 to $3,310,242. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	124	229	$14,610
2019	139	203	$11,206
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	101	19,976	$247,363
2023	448	129,044	$1,695,819
2024	555	191,798	$3,305,846

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	18	70	$3,827
2017	43	174	$7,980
2018	82	247	$20,080
2019	80	316	$33,113
2020	29	55	$48,114
2021	N/R	13	$3,664
2022	30	66	$32,377
2023	142	666	$1,052,077
2024	192	1,241	$3,310,242

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$654

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	107	341	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	264	467	$96
96372	Injection of drug or substance under skin or into muscle	128	404	$11
36415	Insertion of needle into vein for collection of blood sample	373	1,263	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	281	1,020	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	27	756	$602,295
Lenalidomide	Lenalidomide	38	1,064	$389,290
Tagrisso	Osimertinib Mesylate	22	660	$365,791
Calquence	Acalabrutinib Maleate	17	510	$231,057
Revlimid	Lenalidomide	13	364	$214,837

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8700	Temozolomide, oral, 5 mg	N	N/R	11	$654

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$1,519	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charis Durham, M.D.?

Tedicare shows public-source Medicare data for Charis Durham, M.D. (NPI 1538547401), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charis Durham, M.D. have ACO affiliation data?

Charis Durham, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164).

What billing organization is linked to Charis Durham, M.D.?

Charis Durham, M.D. is linked to BRAZOS VALLEY HEMATOLOGY ONCOLOGY ASSOCIATES, PA (billing NPI 1376594432) in the available physician profile data.

Does Charis Durham, M.D. have Open Payments data?

Charis Durham, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.